European Low Dose Risk Research Strategy

Research output: Contribution to report/book/conference proceedingsIn-proceedings paperpeer-review

Standard

European Low Dose Risk Research Strategy. / Salomaa, Sisko; Weiss, Wolfgang; Repussard, Jacques; Bloch, Gilles; Hardeman, Frank; Marcellari, Velio; Harrison, John; Harm-Ringhal, Mats; Vaz, Pedro; Zolzer, Friedo; Jouve, André; Averbeck, Dietrich; Ottolenghi, Andrea; Sabatier, Laure; Atkinson, Michael; Bouffler, Simon; Gourmelon, Patrick; Jourdain, Jean-René; Simone, Giustina; Baatout, Sarah; Jung, Thomas; Cardis, Elisabeth; Hall, Janet; Jacquet, Paul (Peer reviewer); Benotmane, Rafi (Peer reviewer); Vanmarcke, Hans (Peer reviewer).

Proceedings of Third European IRPA Congress 2010. Helsinki, Finland, 2010. p. 1-7 (Proceedings of IRPA Congresses).

Research output: Contribution to report/book/conference proceedingsIn-proceedings paperpeer-review

Harvard

Salomaa, S, Weiss, W, Repussard, J, Bloch, G, Hardeman, F, Marcellari, V, Harrison, J, Harm-Ringhal, M, Vaz, P, Zolzer, F, Jouve, A, Averbeck, D, Ottolenghi, A, Sabatier, L, Atkinson, M, Bouffler, S, Gourmelon, P, Jourdain, J-R, Simone, G, Baatout, S, Jung, T, Cardis, E, Hall, J, Jacquet, P, Benotmane, R & Vanmarcke, H 2010, European Low Dose Risk Research Strategy. in Proceedings of Third European IRPA Congress 2010. Proceedings of IRPA Congresses, Helsinki, Finland, pp. 1-7, IRPA 2010 - 3th European IRPA Congress : Encouraging Sustainability in Radiation Protection - Finland, Helsinki, Finland, 2010-06-14.

APA

Salomaa, S., Weiss, W., Repussard, J., Bloch, G., Hardeman, F., Marcellari, V., Harrison, J., Harm-Ringhal, M., Vaz, P., Zolzer, F., Jouve, A., Averbeck, D., Ottolenghi, A., Sabatier, L., Atkinson, M., Bouffler, S., Gourmelon, P., Jourdain, J-R., Simone, G., ... Vanmarcke, H. (2010). European Low Dose Risk Research Strategy. In Proceedings of Third European IRPA Congress 2010 (pp. 1-7). (Proceedings of IRPA Congresses)..

Vancouver

Salomaa S, Weiss W, Repussard J, Bloch G, Hardeman F, Marcellari V et al. European Low Dose Risk Research Strategy. In Proceedings of Third European IRPA Congress 2010. Helsinki, Finland. 2010. p. 1-7. (Proceedings of IRPA Congresses).

Author

Salomaa, Sisko ; Weiss, Wolfgang ; Repussard, Jacques ; Bloch, Gilles ; Hardeman, Frank ; Marcellari, Velio ; Harrison, John ; Harm-Ringhal, Mats ; Vaz, Pedro ; Zolzer, Friedo ; Jouve, André ; Averbeck, Dietrich ; Ottolenghi, Andrea ; Sabatier, Laure ; Atkinson, Michael ; Bouffler, Simon ; Gourmelon, Patrick ; Jourdain, Jean-René ; Simone, Giustina ; Baatout, Sarah ; Jung, Thomas ; Cardis, Elisabeth ; Hall, Janet ; Jacquet, Paul ; Benotmane, Rafi ; Vanmarcke, Hans. / European Low Dose Risk Research Strategy. Proceedings of Third European IRPA Congress 2010. Helsinki, Finland, 2010. pp. 1-7 (Proceedings of IRPA Congresses).

Bibtex - Download

@inproceedings{5a4d308d01f748d0af3e83bccc2543a5,
title = "European Low Dose Risk Research Strategy",
abstract = "Although much is known about the quantitative effects of exposure to ionising radiation, considerable uncertainties and divergent views remain about the health effects at low doses. Many of the European states have national research programmes in this area, however, beyond the Euratom research programme, little has been done to integrate these programmes in the past. The European High Level and Expert Group (HLEG) recently made a motion for the establishment of a Multidisciplinary European Low Dose Research Initiative (MELODI) that would create a platform for low dose research under a jointly agreed Strategic Research Agenda (www.hleg.de). In 2010, a Network of Excellence called DoReMi was launched by the Euratom FP7 programme. DoReMi will act as an operational tool for the development of the MELODI platform during the next six years. The joint programme for research focuses on the areas identified by the HLEG as the most promising in terms of addressing/resolving the key policy questions, namely: the shape of dose response curve for cancer, individual susceptibilities and non-cancer effects. Radiation quality, tissue sensitivities and internal exposures will be addressed as cross cutting themes within the three main research areas..",
keywords = "radiation protection, low dose, cancer, non-cancer, individual susceptibility",
author = "Sisko Salomaa and Wolfgang Weiss and Jacques Repussard and Gilles Bloch and Frank Hardeman and Velio Marcellari and John Harrison and Mats Harm-Ringhal and Pedro Vaz and Friedo Zolzer and Andr{\'e} Jouve and Dietrich Averbeck and Andrea Ottolenghi and Laure Sabatier and Michael Atkinson and Simon Bouffler and Patrick Gourmelon and Jean-Ren{\'e} Jourdain and Giustina Simone and Sarah Baatout and Thomas Jung and Elisabeth Cardis and Janet Hall and Paul Jacquet and Rafi Benotmane and Hans Vanmarcke",
note = "Score = 3; IRPA 2010 - 3th European IRPA Congress : Encouraging Sustainability in Radiation Protection - Finland ; Conference date: 14-06-2010 Through 18-06-2010",
year = "2010",
month = jun,
day = "15",
language = "English",
series = "Proceedings of IRPA Congresses",
pages = "1--7",
booktitle = "Proceedings of Third European IRPA Congress 2010",
url = "http://www.irpa2010europe.com/",

}

RIS - Download

TY - GEN

T1 - European Low Dose Risk Research Strategy

AU - Salomaa, Sisko

AU - Weiss, Wolfgang

AU - Repussard, Jacques

AU - Bloch, Gilles

AU - Hardeman, Frank

AU - Marcellari, Velio

AU - Harrison, John

AU - Harm-Ringhal, Mats

AU - Vaz, Pedro

AU - Zolzer, Friedo

AU - Jouve, André

AU - Averbeck, Dietrich

AU - Ottolenghi, Andrea

AU - Sabatier, Laure

AU - Atkinson, Michael

AU - Bouffler, Simon

AU - Gourmelon, Patrick

AU - Jourdain, Jean-René

AU - Simone, Giustina

AU - Baatout, Sarah

AU - Jung, Thomas

AU - Cardis, Elisabeth

AU - Hall, Janet

A2 - Jacquet, Paul

A2 - Benotmane, Rafi

A2 - Vanmarcke, Hans

N1 - Score = 3

PY - 2010/6/15

Y1 - 2010/6/15

N2 - Although much is known about the quantitative effects of exposure to ionising radiation, considerable uncertainties and divergent views remain about the health effects at low doses. Many of the European states have national research programmes in this area, however, beyond the Euratom research programme, little has been done to integrate these programmes in the past. The European High Level and Expert Group (HLEG) recently made a motion for the establishment of a Multidisciplinary European Low Dose Research Initiative (MELODI) that would create a platform for low dose research under a jointly agreed Strategic Research Agenda (www.hleg.de). In 2010, a Network of Excellence called DoReMi was launched by the Euratom FP7 programme. DoReMi will act as an operational tool for the development of the MELODI platform during the next six years. The joint programme for research focuses on the areas identified by the HLEG as the most promising in terms of addressing/resolving the key policy questions, namely: the shape of dose response curve for cancer, individual susceptibilities and non-cancer effects. Radiation quality, tissue sensitivities and internal exposures will be addressed as cross cutting themes within the three main research areas..

AB - Although much is known about the quantitative effects of exposure to ionising radiation, considerable uncertainties and divergent views remain about the health effects at low doses. Many of the European states have national research programmes in this area, however, beyond the Euratom research programme, little has been done to integrate these programmes in the past. The European High Level and Expert Group (HLEG) recently made a motion for the establishment of a Multidisciplinary European Low Dose Research Initiative (MELODI) that would create a platform for low dose research under a jointly agreed Strategic Research Agenda (www.hleg.de). In 2010, a Network of Excellence called DoReMi was launched by the Euratom FP7 programme. DoReMi will act as an operational tool for the development of the MELODI platform during the next six years. The joint programme for research focuses on the areas identified by the HLEG as the most promising in terms of addressing/resolving the key policy questions, namely: the shape of dose response curve for cancer, individual susceptibilities and non-cancer effects. Radiation quality, tissue sensitivities and internal exposures will be addressed as cross cutting themes within the three main research areas..

KW - radiation protection

KW - low dose

KW - cancer

KW - non-cancer

KW - individual susceptibility

UR - http://ecm.sckcen.be/OTCS/llisapi.dll/open/ezp_109347

UR - http://knowledgecentre.sckcen.be/so2/bibref/7370

M3 - In-proceedings paper

T3 - Proceedings of IRPA Congresses

SP - 1

EP - 7

BT - Proceedings of Third European IRPA Congress 2010

CY - Helsinki, Finland

T2 - IRPA 2010 - 3th European IRPA Congress : Encouraging Sustainability in Radiation Protection - Finland

Y2 - 14 June 2010 through 18 June 2010

ER -

ID: 306079